Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates

被引:94
作者
Tian, R [1 ]
Koyabu, N [1 ]
Takanaga, H [1 ]
Matsuo, H [1 ]
Ohtani, H [1 ]
Sawada, Y [1 ]
机构
[1] Kyushu Univ, Dept Med Pharmaceut Sci, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
grapefruit juice; orange juice; P-glycoprotein (P-gp); intestinal efflux; fexofenadine; saquinavir;
D O I
10.1023/A:1016100715125
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this study is to investigate the effects of 50% ethyl acetate extracts of grapefruit juice (GFJ) and orange juice (OJ) on the transport activity of P-glycoprotein (P-gp) in the rat small intestine. Methods. The efflux of P-gp substrates from rat everted sac in the absence or presence of verapamil, GFJ, OJ or erythromycin was measured. Rhodamine123, fexofenadine and saquinavir were used as P-gp substrates. P-gp expression levels in the rat jejunum and ileum were determined by Western blot analysis. Results. The efflux of rhodamine123 from the everted sac increased from the apex of the jejunum to the low ileum and the expression of P-gp in the ileum was 2.31-fold higher than that in the jejunum. Verapamil and the 50% GFJ and OJ extracts inhibited the efflux from the intestine of all three drugs tested. Erythromycin decreased the efflux of rhodamine123 and fexofenadine, but did not affect the efflux of saquinavir in the intestine. Conclusions. GFJ and OJ extracts inhibited the efflux of P-gp substrates from the small intestine. Therefore, they may enhance the oral bioavailability of P-gp substrates by increasing absorption in the small intestine.
引用
收藏
页码:802 / 809
页数:8
相关论文
共 30 条
[1]   INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE [J].
BAILEY, DG ;
SPENCE, JD ;
MUNOZ, C ;
ARNOLD, JMO .
LANCET, 1991, 337 (8736) :268-269
[2]   Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse Intestine [J].
Chianale, J ;
Vollrath, V ;
Wielandt, AM ;
Miranda, S ;
Gonzalez, R ;
Fresno, AM ;
Quintana, C ;
Gonzalez, S ;
Andrade, L ;
Guzman, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1264 (03) :369-376
[3]  
Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
[4]  
Eagling VA, 1999, BRIT J CLIN PHARMACO, V48, P543, DOI 10.1046/j.1365-2125.1999.00052.x
[5]   FELODIPINE KINETICS IN HEALTHY-MEN [J].
EDGAR, B ;
REGARDH, CG ;
JOHNSSON, G ;
JOHANSSON, L ;
LUNDBORG, P ;
LOFBERG, I ;
RONN, O .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) :205-211
[6]   6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice:: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein [J].
Edwards, DJ ;
Fitzsimmons, ME ;
Schuetz, EG ;
Yasuda, K ;
Ducharme, MP ;
Warbasse, LH ;
Woster, PM ;
Schuetz, JD ;
Watkins, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (03) :237-244
[7]   Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects [J].
Hashimoto, K ;
Shirafuji, T ;
Sekino, H ;
Matsuoka, O ;
Sekino, H ;
Onnagawa, O ;
Okamoto, T ;
Kudo, S ;
Azuma, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (9-10) :753-760
[8]   Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells [J].
Ikegawa, T ;
Ushigome, F ;
Koyabu, N ;
Morimoto, S ;
Shoyama, Y ;
Naito, M ;
Tsuruo, T ;
Ohtani, H ;
Sawada, Y .
CANCER LETTERS, 2000, 160 (01) :21-28
[9]  
JETTE L, 1996, AM J PHYSIOL, V270, P756
[10]   Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: Does the formulation difference matter? [J].
Ku, YM ;
Min, DI ;
Flanigan, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (10) :959-965